Press
High-Tech Gründerfonds (HTGF) invests in Freiburg-based start-up Blue Inductive
Blue Inductive GmbH develops wireless charging systems and is revolutionising power supply systems for mobile robots deployed in industrial settings.
The maintenance-free systems enable fully automatic charging – without human intervention. This solution eliminates the disadvantages associated with conventional plugs and charging contacts, thus enhancing process efficiency in logistics and production facilities.
Together with Phoenix Contact Innovation Ventures, VC Fonds Baden-Wuert
Press
HTGF welcomes Enscape GmbH, a portfolio spin-off and category leader: 71 out of the TOP100 architectural firms are customers of Enscape after only two years
Enscape™ is a leading global provider of visualization software for architects. The company spun off in 2017 as a separate company from Inreal Technologies GmbH, a HTGF portfolio company since 2012. Enscape’s real time 3D rendering plugin delivers stunning one-click design reviews.
Since the first release, Enscape has upgraded its real-time 3D rendering plugin for Autodesk® Revit® and Trimble® SketchUp®. As the world’s first real-time rendering and virtual reality plugin for the
Press
Venture Capital: Evonik invests in High-Tech Gründerfonds III
Evonik is extending its corporate-venturing activities in Europe with an investment in High-Tech Gründerfonds III (HTGF III). The fund has a targeted fund size of more than €300 million. Evonik will invest an amount in the single-digit million euro range. HTGF is Germany’s most active seed-stage investor. It finances young, innovative technology start-up companies and actively supports them with the implementation of their business ideas. In 2012, Evonik invested in the predecessor fund HTG
Press
STIHL participates in High-Tech Gründerfonds III
The STIHL Group is participating in the High-Tech Gründerfonds (Startup Fund), which is the largest seed fund for financing young technology companies in Germany.
“By investing in the High-Tech Gründerfonds we want to support the development of innovative companies and further expand our activities in the area of research and development”, explained STIHL Executive Board Member, Finance and Controlling, Karl Angler. “The broad investment horizon of the High-Tech Gründerfonds and the
Press
m + mv invests in High-Tech Gründerfonds III
media + more venture Beteiligungs GmbH & Co. KG, a company comprising three regional publishers in Mainz, Freiburg and Heilbronn, is investing EUR 2.5 million in High-Tech Gründerfonds III (HTGF III). The consortium of three publishers is thus once again reinforcing its commitment to and investments in innovative technologies from Germany for the publishing industry.
HTGF III invests venture capital in young, high potential high-tech start-ups that can turn promising research findings in
Press
Haniel invests in High-Tech Gründerfonds
Complementing investments in venture capital funds as part of digital initiative
Haniel, a German family-equity company, has invested in High-Tech Gründerfonds III (HTGF III). With HTGF III, up to 40 technology companies are expected to receive financial support with a target fund volume of €300 million per year. In addition to its financial involvement, the fund offers technology companies the expertise of its own team as well as an extensive network and scouts as support. Haniel benefits
Press
BÜFA fosters innovative tech start-ups
Oldenburg-based chemicals company takes stake in High-Tech Gründerfonds
“I am delighted that BÜFA GmbH & Co. KG has decided to invest in High-Tech Gründerfonds. With your support, we intend to continue the success enjoyed by High-Tech Gründerfonds, a development that benefits Germany as a hub of business,” German cabinet minister Sigmar Gabriel wrote in an official letter to BÜFA, thanking the company for its commitment. The Oldenburg-based chemicals company invested in the third
Press
Drillisch AG invests in High-Tech Gründerfonds
Telecommunication service provider Drillisch AG is investing in the third fund of High-Tech Gründerfonds (HTGF), Germany's most active seed stage investor.
HTGF's third fund is to have a volume of roughly EUR 300 million. Drillisch AG joins an esteemed group of investors in the fund. The company owns a number of renowned brands including smartmobil.de, yourfone, simply, sim.de, McSIM, helloMobil, winSIM and discoTEL.
"The investment in HTGF provides Drillisch AG and its subsidiary compani
Press
Hogg Robinson Group Acquires Digital Travel Innovator
Hogg Robinson Group announces that it has entered into an agreement to acquire the digital travel innovator eWings.com, a next-generation travel management company. The acquisition is expected to complete within the next 15 working days.
A totally online offering, eWings.com provides a fast and easy-to-use solution for digital business travel with a quick to start process and low cost service model which is especially well suited to small businesses that require a simplified digital Service.
Press
WISE Srl raises EUR 6.5 million for clinical validation of novel neuroelectrodes for brain monitoring and spinal cord stimulation
Minimally invasive, highly conformable, foldable and stretchable electrodes for growing Neuromonitoring and Neuromodulation markets being developed
WISE Srl, a medical device company developing next-generation implantable neuromodulation leads announces today the closing of a EUR 6.5 million series B financing round, led by Principia SGR, an Italian Venture Capital firm. Existing investors Atlante Ventures, High-Tech Gründerfonds, F3F and Antares joined the round.
WISE develops novel, highly
Press
High-Tech Gründerfonds (HTGF) invests in Reutlingen-based SIGNATOPE GmbH – Safe medications thanks to new test procedures
High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and allows the early detection of possible side effects during the drug development process. Thereby, the need for animal testing will be reduced while the drug becomes safer and the process more cost-efficient. S
Press
TolerogenixX secures seed funding and completes Phase I clinical trial
TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the immune system’s defences. In a Phase I clinical trial, the technique was successfully employed during kidney transplants. Patients who received transplants became tolerant of the donated organ. As a seed stage investor, High-Tech Gründerfonds (HTGF) will finance thi
Press
EcoIntense Announces €22 million Growth Capital Investment from One Peak Partners and Morgan Stanley Expansion Capital
EcoIntense GmbH today announced the completion of a €22 million investment from private equity firm One Peak Partners and investment funds managed by Morgan Stanley Expansion Capital, the growth-focused private investment team within Morgan Stanley Investment Management. The funding will be primarily used to invest in the company’s international growth trajectory and product development.
EcoIntense is one of Europe’s leading software providers for health and safety, environmental manage
Press
MoBerries closes € 1.8M funding for AI-driven HR network
The Berlin-based company has received the backing of 42CAP, High-Tech Gründerfonds (HTGF), LITTLEROCK and several renowned angel investors such as Michael Brehm, Roman Kirsch and Tim Stracke as it begins to roll out its SaaS service. The on-demand recruitment platform allows companies to hire qualified candidates fast.
The company raised a 7-figure funding round from 42cap, HTGF, LITTLEROCK, several hedge fund managers, and well-known business angels such as Michael Brehm, Thomas Baum, Dr. M
Press
Cardior Pharmaceuticals raises €15 million to develop first-in-class ncRNA therapeutics and diagnostics for patients with myocardial infarction and heart failure
Cardior Pharmaceuticals, a spin-off from Hannover Medical School (MHH), today announced the completion of a €15 million Series A financing round led by LSP (Life Sciences Partners), Boehringer Ingelheim Venture Fund (BIVF), Bristol-Myers Squibb (BMS), BioMedPartners (with its new BioMedInvest III Fund) and High-Tech Gründerfonds (HTGF). Cardior is pioneering its proprietary RNA technology to revolutionize predicting and treating heart failure. The molecular targets are non-coding RNAs linked
Press
NUMAFERM revolutionizes peptide production and receives seed financing
The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving funding in the seven-digit range. High-Tech Gründerfonds (HTGF), Qiagen co-founders and European Business Angels Prof. Detlev Riesner and Dr. Jürgen Schumacher, as well as the Eur